Twinpig Biolab researches and develops anticancer drugs.
Twinpig Biolab has raised $1.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2025.
Twinpig Biolab's investors include Scale Up Partners.
Twinpig Biolab is headquartered in Seoul, South Korea.
Twinpig Biolab researches and develops anticancer drugs.
Twinpig Biolab is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Twinpig Biolab — Funding & Investors." VCBacked, November 20, 2025, https://www.vcbacked.co/company/twinpig-biolab. Accessed September 30, 2026.
VCBacked. (2025). Twinpig Biolab — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/twinpig-biolab
{{cite web |title=Twinpig Biolab — Funding & Investors |url=https://www.vcbacked.co/company/twinpig-biolab |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated